NCT00313937View on ClinicalTrials.gov

SAM - Skip a Meal - Insulin Glargine, Diabetes Mellitus Type 1

PHASE4CompletedINTERVENTIONAL
Enrollment

91

Participants

Timeline

Start Date

November 30, 2001

Primary Completion Date

June 30, 2004

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

Insulin glargine

Trial Locations (1)

Unknown

Sanofi-Aventis, Berlin

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00313937 - SAM - Skip a Meal - Insulin Glargine, Diabetes Mellitus Type 1 | Biotech Hunter | Biotech Hunter